Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Simler

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Protein Engineering, Design & Selection : PEDS|March 31, 2004
Zinc binding drives the folding and association of the homo-trimeric gamma-carbonic anhydrase from Methanosarcina thermophilaB Robert Simler, Brandon L Doyle, C Robert Matthews
Journal of Pharmaceutical Sciences|August 23, 2012
Mechanistic complexity of subvisible particle formation: links to protein aggregation are highly specificB Robert Simler, Guodong Hui, Jennifer E Dahl, et al.
Journal of Molecular Biology|September 8, 2006
The folding energy landscape of the dimerization domain of Escherichia coli Trp repressor: a joint experimental and theoretical investigationB Robert Simler, Yaakov Levy, José N Onuchic, et al.
Advanced Drug Delivery Reviews|October 22, 2011
Viscosity of concentrated therapeutic protein compositionsJan Jezek, Martin Rides, Barry Derham, et al.
Nucleic Acid Therapeutics|May 8, 2020
Technical Considerations for Use of Oligonucleotide Solution APIJale Muslehiddinoglu, Robert Simler, Malcolm L Hill, et al.
Journal of Pharmaceutical Sciences|April 3, 2015
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and StrategyLinda O Narhi, Vincent Corvari, Dean C Ripple, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 2, 2015
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysisVincent Corvari, Linda O Narhi, Thomas M Spitznagel, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Protein Engineering, Design & Selection : PEDS|March 31, 2004
Zinc binding drives the folding and association of the homo-trimeric gamma-carbonic anhydrase from Methanosarcina thermophilaB Robert Simler, Brandon L Doyle, C Robert Matthews
Journal of Pharmaceutical Sciences|August 23, 2012
Mechanistic complexity of subvisible particle formation: links to protein aggregation are highly specificB Robert Simler, Guodong Hui, Jennifer E Dahl, et al.
Journal of Molecular Biology|September 8, 2006
The folding energy landscape of the dimerization domain of Escherichia coli Trp repressor: a joint experimental and theoretical investigationB Robert Simler, Yaakov Levy, José N Onuchic, et al.
Advanced Drug Delivery Reviews|October 22, 2011
Viscosity of concentrated therapeutic protein compositionsJan Jezek, Martin Rides, Barry Derham, et al.
Nucleic Acid Therapeutics|May 8, 2020
Technical Considerations for Use of Oligonucleotide Solution APIJale Muslehiddinoglu, Robert Simler, Malcolm L Hill, et al.
Journal of Pharmaceutical Sciences|April 3, 2015
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and StrategyLinda O Narhi, Vincent Corvari, Dean C Ripple, et al.
Biologicals : Journal of the International Association of Biological Standardization|September 2, 2015
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysisVincent Corvari, Linda O Narhi, Thomas M Spitznagel, et al.
Pageof 1